Is Bausch Health Companies Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: BHC) stock is to Hold BHC stock.
Out of 2 analysts, 0 (0%) are recommending BHC as a Strong Buy, 0 (0%) are recommending BHC as a Buy, 2 (100%) are recommending BHC as a Hold, 0 (0%) are recommending BHC as a Sell, and 0 (0%) are recommending BHC as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year BHC price target, the average BHC price target is $7.50, with the highest BHC stock price forecast at $8.00 and the lowest BHC stock price forecast at $7.00.
On average, Wall Street analysts predict that Bausch Health Companies's share price could reach $7.50 by Feb 25, 2027. The average Bausch Health Companies stock price prediction forecasts a potential upside of 49.7% from the current BHC share price of $5.01.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.